Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 3
2020 1
2021 4
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Plasma miRNA-based signatures in CRC screening programs.
Zanutto S, Ciniselli CM, Belfiore A, Lecchi M, Masci E, Delconte G, Primignani M, Tosetti G, Dal Fante M, Fazzini L, Airoldi A, Vangeli M, Turpini F, Rubis Passoni GG, Viaggi P, Arena M, Motta RIO, Cantù AM, Crosta C, De Roberto G, Iannuzzi F, Cassinotti A, Dall'Olio V, Tizzoni L, Sozzi G, Meroni E, Bisanti L, Pierotti MA, Verderio P, Gariboldi M. Zanutto S, et al. Among authors: lecchi m. Int J Cancer. 2020 Feb 15;146(4):1164-1173. doi: 10.1002/ijc.32573. Epub 2019 Aug 5. Int J Cancer. 2020. PMID: 31304978 Free article.
Retrospective study of late radiation-induced damages after focal radiotherapy for childhood brain tumors.
Cavatorta C, Meroni S, Montin E, Oprandi MC, Pecori E, Lecchi M, Diletto B, Alessandro O, Peruzzo D, Biassoni V, Schiavello E, Bologna M, Massimino M, Poggi G, Mainardi L, Arrigoni F, Spreafico F, Verderio P, Pignoli E, Gandola L. Cavatorta C, et al. Among authors: lecchi m. PLoS One. 2021 Feb 26;16(2):e0247748. doi: 10.1371/journal.pone.0247748. eCollection 2021. PLoS One. 2021. PMID: 33635906 Free PMC article.
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.
Lecchi M, Verderio P, Cappelletti V, De Santis F, Paolini B, Monica M, Sangaletti S, Pupa SM, Iorio MV, Bianchi G, Gennaro M, Fucà G, De Braud F, Tagliabue E, Di Nicola M. Lecchi M, et al. Mol Oncol. 2021 May;15(5):1345-1357. doi: 10.1002/1878-0261.12912. Epub 2021 Feb 19. Mol Oncol. 2021. PMID: 33523584 Free PMC article.
Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended.
Giussani M, Ciniselli CM, De Cecco L, Lecchi M, Dugo M, Gargiuli C, Mariancini A, Mancinelli E, Cosentino G, Veneroni S, Paolini B, Orlandi R, Gennaro M, Iorio MV, Depretto C, Ferranti C, Sozzi G, Sensi M, Colombo MP, Scaperrotta G, Tagliabue E, Verderio P. Giussani M, et al. Among authors: lecchi m. Cancers (Basel). 2021 Aug 10;13(16):4028. doi: 10.3390/cancers13164028. Cancers (Basel). 2021. PMID: 34439180 Free PMC article.
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables.
Gandellini P, Ciniselli CM, Rancati T, Marenghi C, Doldi V, El Bezawy R, Lecchi M, Claps M, Catanzaro M, Avuzzi B, Campi E, Colecchia M, Badenchini F, Verderio P, Valdagni R, Zaffaroni N. Gandellini P, et al. Among authors: lecchi m. Cancers (Basel). 2021 May 18;13(10):2433. doi: 10.3390/cancers13102433. Cancers (Basel). 2021. PMID: 34069838 Free PMC article.
Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation.
Tripodo C, Bassani B, Jachetti E, Cancila V, Chiodoni C, Portararo P, Botti L, Valenti C, Perrone M, Ponzoni M, Comoli P, Lecchi M, Verderio P, Curti A, Colombo MP, Sangaletti S. Tripodo C, et al. Among authors: lecchi m. Elife. 2022 Apr 26;11:e69257. doi: 10.7554/eLife.69257. Elife. 2022. PMID: 35471185 Free PMC article.
Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies.
Cona MS, Lecchi M, Cresta S, Damian S, Del Vecchio M, Necchi A, Poggi MM, Raggi D, Randon G, Ratta R, Signorelli D, Vernieri C, de Braud F, Verderio P, Di Nicola M. Cona MS, et al. Among authors: lecchi m. Cancers (Basel). 2019 Feb 14;11(2):223. doi: 10.3390/cancers11020223. Cancers (Basel). 2019. PMID: 30769874 Free PMC article.
Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
Fina E, Cleris L, Dugo M, Lecchi M, Ciniselli CM, Lecis D, Bianchi GV, Verderio P, Daidone MG, Cappelletti V. Fina E, et al. Among authors: lecchi m. J Exp Clin Cancer Res. 2022 Feb 25;41(1):78. doi: 10.1186/s13046-022-02259-8. J Exp Clin Cancer Res. 2022. PMID: 35216615 Free PMC article.